pegfilgrastim-gema

pegfilgrastim-gema · Gema Biotech S.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for pegfilgrastim-gema, covering 2018-01-19 to 2018-01-19. Get the full timeline:

Most recent: Clinical Trial Update: Pegfilgrastim-gema Compared to Pegfilgrastim-roche for Prevention of Induced Neutropenia in Breast Cancer Patients. [Phase 3]

See pricing